BRPI0821327A2 - Derivado de catecol, composição farmacêutica contendo o mesmo, uso do derivado de catecol, e uso da composição farmacêutica - Google Patents
Derivado de catecol, composição farmacêutica contendo o mesmo, uso do derivado de catecol, e uso da composição farmacêuticaInfo
- Publication number
- BRPI0821327A2 BRPI0821327A2 BRPI0821327-5A BRPI0821327A BRPI0821327A2 BR PI0821327 A2 BRPI0821327 A2 BR PI0821327A2 BR PI0821327 A BRPI0821327 A BR PI0821327A BR PI0821327 A2 BRPI0821327 A2 BR PI0821327A2
- Authority
- BR
- Brazil
- Prior art keywords
- pharmaceutical composition
- catechol derivative
- containing same
- composition containing
- catechol
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Neurosurgery (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2007331896 | 2007-12-25 | ||
| PCT/JP2008/073269 WO2009081891A1 (ja) | 2007-12-25 | 2008-12-22 | 新規なカテコール誘導体、それを含有する医薬組成物およびそれらの用途 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0821327A2 true BRPI0821327A2 (pt) | 2015-06-16 |
Family
ID=40801192
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0821327-5A BRPI0821327A2 (pt) | 2007-12-25 | 2008-12-22 | Derivado de catecol, composição farmacêutica contendo o mesmo, uso do derivado de catecol, e uso da composição farmacêutica |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US7923462B2 (pt) |
| EP (1) | EP2246338B1 (pt) |
| JP (1) | JP5279728B2 (pt) |
| KR (1) | KR101613610B1 (pt) |
| CN (1) | CN101965339B (pt) |
| AU (1) | AU2008342122B2 (pt) |
| BR (1) | BRPI0821327A2 (pt) |
| CA (1) | CA2708447C (pt) |
| IL (1) | IL206562A (pt) |
| MX (1) | MX2010006882A (pt) |
| RU (1) | RU2459812C2 (pt) |
| TW (1) | TWI415607B (pt) |
| WO (1) | WO2009081891A1 (pt) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5433505B2 (ja) * | 2009-06-18 | 2014-03-05 | キッセイ薬品工業株式会社 | ニトロカテコール誘導体の製造方法およびその製造中間体 |
| KR101799429B1 (ko) * | 2010-05-03 | 2017-11-21 | 에스케이바이오팜 주식회사 | 신경 세포 사멸 또는 신경 퇴화를 억제하기 위한 약학적 조성물 |
| JP5883590B2 (ja) * | 2010-08-06 | 2016-03-15 | キッセイ薬品工業株式会社 | 新規なカテコール誘導体、それを含有する医薬組成物およびそれらの用途 |
| WO2013066835A2 (en) * | 2011-10-31 | 2013-05-10 | Glaxosmithkline Llc | Compounds and methods |
| TWI638802B (zh) | 2012-05-24 | 2018-10-21 | 芬蘭商奧利安公司 | 兒茶酚ｏ－甲基轉移酶活性抑制化合物 |
| RU2512293C1 (ru) * | 2012-12-13 | 2014-04-10 | Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Ярославский государственный технический университет" | Способ получения этил 1,2,4-оксадиазол-5-карбоксилатов |
| ES2634014T3 (es) | 2013-01-30 | 2017-09-26 | Bayer Pharma Aktiengesellschaft | Isotiazoles sustituidos con amino |
| GB201507340D0 (en) | 2015-04-29 | 2015-06-10 | Univ St Andrews | Light emitting devices and compounds |
| WO2017103278A1 (en) * | 2015-12-18 | 2017-06-22 | Caprotec Bioanalytics Gmbh | Novel bicyclic-compounds for use as a medicament, in particular for treatment of parkinson's disease |
| CN106478394A (zh) * | 2016-09-29 | 2017-03-08 | 贵州大学 | 一种1‑(2‑羟基‑3‑甲氧苯基)乙酮的制备工艺 |
| CN113979962A (zh) * | 2017-03-31 | 2022-01-28 | 先正达参股股份有限公司 | 杀真菌组合物 |
| TWI829634B (zh) * | 2017-04-06 | 2024-01-21 | 美商富曼西公司 | 殺真菌之噁二唑 |
| WO2019020501A1 (en) * | 2017-07-28 | 2019-01-31 | Basf Se | PREPARATION OF SUBSTITUTED 3-ARYL-5-TRIFLUOROMETHYL-1,2,4-OXADIAZOLES |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SU776031A1 (ru) * | 1979-03-01 | 1982-01-23 | Пермский государственный фармацевтический институт | N-метилфенацил-5-(3-фенил 1,2,4-оксадиазолил)кетон,про вл ющий антимикробную активность |
| DK175069B1 (da) * | 1986-03-11 | 2004-05-24 | Hoffmann La Roche | Pyrocatecholderivater |
| US5236952A (en) | 1986-03-11 | 1993-08-17 | Hoffmann-La Roche Inc. | Catechol derivatives |
| YU213587A (en) | 1986-11-28 | 1989-06-30 | Orion Yhtymae Oy | Process for obtaining new pharmacologic active cateholic derivatives |
| US4871753A (en) | 1986-12-12 | 1989-10-03 | Ciba-Geigy Corporation | 3-Phenyl-5-trifluoromethyl-1,2,4-oxadiazole compounds which are useful pesticides |
| ZA879329B (en) * | 1986-12-12 | 1988-06-13 | Ciba-Geigy Ag | Pesticides |
| DE10208986A1 (de) * | 2002-02-28 | 2003-09-11 | Aventis Pharma Gmbh | Verwendung substituierter 3-Phenyl-5-alkoxi-1,3,4-oxdiazol-2-one zur Herstellung von Arzneimitteln mit hemmender Wirkung an der pankreatischen Lipase |
| HUE059464T2 (hu) * | 2003-04-11 | 2022-11-28 | Ptc Therapeutics Inc | 1,2,4-Oxadiazolbenzoesav-vegyületek és ezek alkalmazása nonsense szuppresszióhoz és betegségek kezelésére |
| AU2006272978B2 (en) * | 2005-07-26 | 2012-06-07 | Bial - Portela & Ca, S.A. | Nitrocatechol derivatives as COMT inhibitors |
| EP1845097A1 (en) * | 2006-04-10 | 2007-10-17 | Portela & Ca., S.A. | Oxadiazole derivatives as COMT inhibitors |
-
2008
- 2008-12-22 JP JP2009547092A patent/JP5279728B2/ja not_active Expired - Fee Related
- 2008-12-22 KR KR1020107014781A patent/KR101613610B1/ko not_active IP Right Cessation
- 2008-12-22 MX MX2010006882A patent/MX2010006882A/es active IP Right Grant
- 2008-12-22 TW TW097150071A patent/TWI415607B/zh not_active IP Right Cessation
- 2008-12-22 AU AU2008342122A patent/AU2008342122B2/en not_active Ceased
- 2008-12-22 WO PCT/JP2008/073269 patent/WO2009081891A1/ja active Application Filing
- 2008-12-22 EP EP08864966.0A patent/EP2246338B1/en not_active Not-in-force
- 2008-12-22 BR BRPI0821327-5A patent/BRPI0821327A2/pt not_active IP Right Cessation
- 2008-12-22 US US12/810,275 patent/US7923462B2/en not_active Expired - Fee Related
- 2008-12-22 RU RU2010125903/04A patent/RU2459812C2/ru not_active IP Right Cessation
- 2008-12-22 CA CA2708447A patent/CA2708447C/en not_active Expired - Fee Related
- 2008-12-22 CN CN200880127450XA patent/CN101965339B/zh not_active Expired - Fee Related
-
2010
- 2010-06-23 IL IL206562A patent/IL206562A/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| JP5279728B2 (ja) | 2013-09-04 |
| CN101965339A (zh) | 2011-02-02 |
| KR20100099718A (ko) | 2010-09-13 |
| TWI415607B (zh) | 2013-11-21 |
| AU2008342122B2 (en) | 2012-06-14 |
| WO2009081891A1 (ja) | 2009-07-02 |
| KR101613610B1 (ko) | 2016-04-19 |
| US20100280083A1 (en) | 2010-11-04 |
| EP2246338A1 (en) | 2010-11-03 |
| CA2708447A1 (en) | 2009-07-02 |
| IL206562A (en) | 2014-08-31 |
| RU2010125903A (ru) | 2011-12-27 |
| US7923462B2 (en) | 2011-04-12 |
| TW200940055A (en) | 2009-10-01 |
| IL206562A0 (en) | 2010-12-30 |
| CN101965339B (zh) | 2013-08-14 |
| EP2246338A4 (en) | 2012-03-21 |
| MX2010006882A (es) | 2010-10-05 |
| JPWO2009081891A1 (ja) | 2011-05-06 |
| EP2246338B1 (en) | 2013-11-20 |
| CA2708447C (en) | 2016-05-10 |
| AU2008342122A1 (en) | 2009-07-02 |
| RU2459812C2 (ru) | 2012-08-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0821327A2 (pt) | Derivado de catecol, composição farmacêutica contendo o mesmo, uso do derivado de catecol, e uso da composição farmacêutica | |
| BRPI0821115A2 (pt) | Composto derivado de aminotriazol, medicamento, composição farmacêutica e uso do composto | |
| BRPI0912717A2 (pt) | Composição farmacêutica, e, uso de 5-azacitidina | |
| BRPI0820899A2 (pt) | Formulação cosmética, e, uso da composição | |
| BRPI0815190A2 (pt) | Composto derivado de piridina, composição farmacêutica que o compreende e uso do mesmo | |
| BR112012003842A2 (pt) | composição farmacêutica, método de formulação e uso da mesma | |
| BRPI0810696A2 (pt) | Composto, composição farmacêutica, e, uso de um composto | |
| BRPI0914343A2 (pt) | composição, produto, uso da composição e método | |
| BRPI0913726A2 (pt) | rapalogs, composições farmacêuticas, métodos de preparo e uso dos mesmos | |
| BRPI0919942A2 (pt) | Composto, composição farmacêutica, e, uso de um composto | |
| BRPI0907562A2 (pt) | composto, composição farmacêutica, e, uso de um composto | |
| BRPI0921375A2 (pt) | composto, composição farmacêutica, e, uso de um composto | |
| BRPI0819218A2 (pt) | Métodos, estojos e composições para administração de compostos farmacêuticos | |
| BRPI1011876A2 (pt) | "composição farmacêutica estável e métodos de uso da mesma" | |
| BRPI0917315A2 (pt) | anticorpo, composicao farmaceutico, e, uso de uma composicao farmaceutica | |
| BRPI0915120A2 (pt) | composto derivado de oxima, uso do referido composto e composição farmacêutica | |
| BRPI0816350A2 (pt) | Composições orais, produtos e métodos de uso | |
| BRPI0809667A2 (pt) | Composto, medicamento e composição farmacêutica que o contém e uso do composto | |
| BRPI0810161A2 (pt) | Composto, preparação farmacêutica, composição farmacêutica, e, uso de um composto | |
| BRPI0917661A2 (pt) | produto que contém macitentan, composição farmacêutica que o contém e uso de macitentan | |
| BRPI0921699A2 (pt) | complexo antioxidante, composicoes cosmeticas e farmaceutica contendo o referido complexo e uso deste complexo | |
| BRPI0921879A2 (pt) | composto, composição farmacêutica , e, uso de um composto | |
| BRPI0917579A2 (pt) | composto, composição farmacêutica, métodos, e, uso de um composto | |
| BRPI0907892A2 (pt) | Composto antibiótico azatricíclico, medicamento, composição farmacêutica que o contém e uso do mesmo | |
| IL200153A (en) | History of Ethnon, including and use of pharmaceutical preparations |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 10A ANUIDADE. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2495 DE 30-10-2018 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |